Digital Biomanufacturing Market Trends That Will Shape the Next Decade: Insights from Innovative Solutions For A Sustainable Future In Digital Biomanufacturing

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Digital Biomanufacturing Market Size By 2025?
The market size of digital biomanufacturing has seen swift expansion in the past few years. It is projected to rise from $21.11 billion in 2024 to $23.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.4%. Factors such as the growing complexity of biopharmaceuticals, the increase in personalized medicine, the necessity for cost-effective production, bioprocess optimization, as well as quality control and regulatory compliance, have all contributed to the growth during the historic period.

How Big Is the Digital Biomanufacturing Market Size Expected to Grow by 2029?
The market size of digital biomanufacturing is poised for swift expansion in the following years, with projections suggesting it will reach a value of $38.59 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 13.2%. This advancement throughout the prediction period can be credited to the use of blockchain for a transparent supply chain, the introduction of advanced process control (APC) systems, a focus on sustainability, as well as the creation of interconnected biomanufacturing ecosystems and biomanufacturing emergence in new markets. Key trends for this period involve the incorporation of artificial intelligence (AI), the establishment of digital twins for bioprocessing, improvements in the field of biotechnology, the integration of Industry 4.0, along with real-time monitoring and control.

View the full report here:
https://www.thebusinessresearchcompany.com/report/digital-biomanufacturing-global-market-report

Which Key Market Drivers Powering Digital Biomanufacturing Market Expansion and Growth?
The increasing need for biologics is anticipated to fuel the expansion of the digital biomanufacturing market in the future. Biologics encompass a broad range of pharmaceuticals such as vaccines, growth factors, immunological modulators, monoclonal antibodies, and drugs derived from human blood and plasma. Digital biomanufacturing contributes to the improvement of biologics production by enhancing processes, quality control, reducing expenses, and minimizing production duration, thereby enabling producers to adopt data-reliant strategies and advanced technology to meet the escalating biologics demand more effectively and sustainably. For example, as stated by Cell & Gene, a US-based online resource for research scholars, in February 2023, there were 27 FDA-approved cell and gene therapies (CGTs), making up roughly 8% of the 340 approved biologics in 2022, up from 22 sanctioned in 2021. Hence, the surging demand for biologics fuels the growth of the digital biomanufacturing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10828&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Digital Biomanufacturing Market?
Top firms in the market are concentrating on novel solutions like single-use bioprocessing systems to maintain their market foothold. Single-use bioprocessing systems are designed to boost digital biomanufacturing through flexibility, real-time supervision, minimized risk of contamination, and cost effectiveness. For example, in October 2022, PharmNXT Biotech LLP, a biotech startup based in India, introduced its pioneering integrated manufacturing facility in Pune, aiming to provide single-use bioprocessing solutions. This modern facility is dedicated to meet the hurdles of biologics manufacturing within the nation. The facility is expected to create jobs for between 100 and 200 individuals and will address the needs of international markets including Singapore, Korea, Europe, and the US. The innovative manufacturing unit will participate in the production of the Xelta line of single-use bioprocessing goods and 'NXTmix', a levitating mixing technology.

What Are the Emerging Segments in the Digital Biomanufacturing Market?
The digital biomanufacturingmarket covered in this report is segmented -

1) By Type: Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types
2) By Types Of Biologic(s) Manufactured: Antibodies, Cell And Gene Therapies, Proteins, Vaccines, Other Types
3) By Technology: AI And IoMT Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics And Digital Twin Technologies, Other Technologies
4) By Application: BioProcess Optimization, Biomanufacturing Process Automation And Control, Other Applications
5) By End User: Biopharmaceutical Companies, Academic And Research Institutes

Subsegments:
1) By Manufacturing Technologies: Cell Culture Technologies, Fermentation Technologies, Continuous Manufacturing Processes, Bioreactor Technologies
2) By Analytical And Process Control Technologies: Process Analytical Technology (PAT), Quality Control And Assurance Systems, Real-Time Monitoring Systems, Data Analytics And Visualization Tools
3) By Software: Enterprise Resource Planning (ERP) Systems, Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), Supply Chain Management Software
4) By Other Types: Robotics And Automation Solutions, Digital Twin Technologies, Internet Of Things (IoT) Solutions For Biomanufacturing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10828&type=smp

Who Are the Global Leaders in the Digital Biomanufacturing Market?
Major companies operating in the digital biomanufacturing market include Sanofi SA, Thermo Fisher Scientific Inc., Honeywell International Inc., 3M Company, SAP SE, Danaher Corporation, ABB AG, Siemens Healthineers AG, Emerson Electric Co, GE HealthCare Technologies Inc., Atos SE, Agilent Technologies Inc., Cytiva Europe GmbH, Lonza Group AG, Dassault Systèmes SE, Sartorius AG, BioMérieux, Donaldson Company Inc., Pall Corporation, Eppendorf AG, Symphony Innovation LLC, Koch Membrane Systems Inc., Culture Biosciences Inc., Bota Biosciences Inc., Shimadzu Corporation, e-MSion, Exponential Genomics Inc., Immersciobio GmbH

Which are the Top Profitable Regional Markets for the Digital Biomanufacturing Industry?
North America was the largest region in the digital biomanufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global digital biomanufacturing market during the forecast period. The regions covered in the digital biomanufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10828

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.